Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Interleukin-6 may play a role in causing alopecia areata.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

CD2 might be a new treatment target for patchy alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Researchers found four genes that could help diagnose severe alopecia areata early.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Platelet rich plasma is an effective treatment for alopecia areata.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

PPARα agonists may help treat alopecia areata by reducing inflammation.